Analysed NEUROGENE INC (NGNE:NASDAQ) News Sources
Neurogene Announces Successful Completion of Dosing in Embolden™ Registrational Trial of NGN-401 for Rett Syndrome
08-06-2026
yahoo.com
Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates
11-08-2026
yahoo.com
Neurogene Reports Positive Long-term Clinical Data from Phase 1/2 Trial of NGN-401 Gene Therapy for Rett Syndrome
29-06-2026
yahoo.com
Neurogene to Participate in H.C. Wainwright 28th Annual Global Investment Conference
08-09-2026
yahoo.com
What is the current price of NEUROGENE INC (NGNE:NASDAQ)?
The current price of NEUROGENE INC (NGNE:NASDAQ) is $26.4.
NEUROGENE INC (NGNE:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUROGENE INC (NGNE:NASDAQ) since the previous trading day is $-0.1.
NEUROGENE INC (NGNE:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUROGENE INC (NGNE:NASDAQ) since the previous trading day is -0.3774%.
What is the most recent average sentiment score for NEUROGENE INC (NGNE:NASDAQ)?
The most recent average sentiment score for NEUROGENE INC (NGNE:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for NEUROGENE INC (NGNE:NASDAQ)?
The most recent sentiment for NEUROGENE INC (NGNE:NASDAQ) is .
SEC-8K** Filing Available For NEUROGENE INC (NGNE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.